StockSelector.com
  Research, Select, & Monitor Saturday, August 15, 2020 1:34:57 PM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Altimmune, Inc.$24.66$.964.05%

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

Altimmune, Inc. has an overall rank of 7399 out of 7414 stocks based on 4 positive rankings and 14 negative rankings.

Positive Rankings
Target Prices
The average analysts' target price is $65.00 for Altimmune using target prices set or adjusted within the past 90 days. Among companies with recent target prices and with the average above the current stock price, Altimmune is ranked 48.
Top Industry Values
Altimmune rank is 60
90 Day Gain
Altimmune rank is 73
Debt-to-Equity
Altimmune rank is 361
Negative Rankings
Down Estimate Revision
During the past month, the consensus earnings estimate for the current year and next year have decreased by a combined (99.70%). Among companies that have had their estimates lowerec within the past month, Altimmune is ranked 39.
Down Ratings Revision
During the past month, the average analyst's rating or recommendation has decreased. Among companies that have been downgraded within the past month, Altimmune is ranked 41.
Negative Cash Growth
Altimmune rank is 53
Price-to-Sales
Altimmune rank is 124
Negative Net Margin
Altimmune rank is 242
Negative Revenue Growth
Altimmune rank is 354
High/Dropping MACD
The MACD remains positive, but is dropping... suggesting a possible near-term correction. Of companies with a positive, but declining MACD, Altimmune is ranked 426.
Price-to-Book
Altimmune rank is 598
10 Day Loss
Altimmune rank is 627
Negative ROA
Altimmune rank is 702
Negative ROE
Altimmune rank is 732
High Put/Call
Altimmune has a high Put/Call ratio of 0.90 on all open interest of options expiring in the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, Altimmune is ranked 792.
Down EPS Surprise
Altimmune missed the consensus earnings estimate when it last reported quarterly earnings.
High vPut/Call
Altimmune has a high Put/Call ratio of 0.60 on active options expiring within the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, Altimmune is ranked 1587.







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2020 StockSelector.com. All rights reserved.